Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-11

AUTHORS

Kentaro Maejima, Akira Tokunaga, Teruo Kiyama, Hitoshi Kanno, Hideki Bou, Masanori Watanabe, Hideyuki Suzuki, Eiji Uchida

ABSTRACT

BackgroundChemosensitivity tests have long been discussed but remain a topic of research. In this study, we investigated the correlation between the results of a chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine and the clinical outcomes of gastric cancer patients treated with S-1, an oral fluoropyrimidine, as adjuvant chemotherapy.MethodsFor gastric cancer patients, we performed surgical treatment and a lymph node dissection of D2 or more. Afterwards, a chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine was performed, using the collagen gel droplet embedded culture drug-sensitivity test (CD-DST), in surgical specimens. All the patients received postoperative adjuvant chemotherapy with S-1 for 1 year, and the overall survival (OS), relapse-free survival (RFS), and adverse events were investigated.ResultsThe chemosensitivity test was performed for 27 patients. The growth inhibition rate (IR) was 50% or more (high-sensitivity group) in 59.3% (16 cases) and it was under 50% (low-sensitivity group) in 40.7% (11 cases). The 3-year OS rate was 100% in the high-sensitivity group and 62.34% in the low-sensitivity group. The 3-year RFS rate was 83.33% in the high-sensitivity group and 24.24% in the low-sensitivity group. Thus, the 3-year OS rate and the 3-year RFS rate were higher in the high-sensitivity group than in the low-sensitivity group. No adverse events of grade 3 or greater severity were observed.ConclusionsThe results of the chemosensitivity test were correlated with the patient outcome. Therefore, such results might be useful for individualizing cancer chemotherapy and for determining future indications for postoperative adjuvant chemotherapy. More... »

PAGES

231-237

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10120-010-0564-1

DOI

http://dx.doi.org/10.1007/s10120-010-0564-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043364490

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21128058


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Combinations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxonic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stomach Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tegafur", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.459842.6", 
          "name": [
            "Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maejima", 
        "givenName": "Kentaro", 
        "id": "sg:person.01274243317.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274243317.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.459842.6", 
          "name": [
            "Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tokunaga", 
        "givenName": "Akira", 
        "id": "sg:person.01256300732.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256300732.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Nippon Medical School, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410821.e", 
          "name": [
            "Department of Surgery, Nippon Medical School, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kiyama", 
        "givenName": "Teruo", 
        "id": "sg:person.01365303072.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365303072.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Nippon Medical School, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410821.e", 
          "name": [
            "Department of Surgery, Nippon Medical School, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kanno", 
        "givenName": "Hitoshi", 
        "id": "sg:person.01332141105.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332141105.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.459842.6", 
          "name": [
            "Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bou", 
        "givenName": "Hideki", 
        "id": "sg:person.01202375123.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202375123.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.459842.6", 
          "name": [
            "Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Watanabe", 
        "givenName": "Masanori", 
        "id": "sg:person.01002352347.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002352347.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.459842.6", 
          "name": [
            "Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suzuki", 
        "givenName": "Hideyuki", 
        "id": "sg:person.0623234375.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623234375.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Nippon Medical School, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410821.e", 
          "name": [
            "Department of Surgery, Nippon Medical School, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Uchida", 
        "givenName": "Eiji", 
        "id": "sg:person.0663153457.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663153457.61"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10147-006-0618-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010144924", 
          "https://doi.org/10.1007/s10147-006-0618-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10120-006-0366-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026373016", 
          "https://doi.org/10.1007/s10120-006-0366-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-19022-3_5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019330547", 
          "https://doi.org/10.1007/978-3-642-19022-3_5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00595-003-2569-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003204853", 
          "https://doi.org/10.1007/s00595-003-2569-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-11", 
    "datePublishedReg": "2010-11-01", 
    "description": "BackgroundChemosensitivity tests have long been discussed but remain a topic of research. In this study, we investigated the correlation between the results of a chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine and the clinical outcomes of gastric cancer patients treated with S-1, an oral fluoropyrimidine, as adjuvant chemotherapy.MethodsFor gastric cancer patients, we performed surgical treatment and a lymph node dissection of D2 or more. Afterwards, a chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine was performed, using the collagen gel droplet embedded culture drug-sensitivity test (CD-DST), in surgical specimens. All the patients received postoperative adjuvant chemotherapy with S-1 for 1 year, and the overall survival (OS), relapse-free survival (RFS), and adverse events were investigated.ResultsThe chemosensitivity test was performed for 27 patients. The growth inhibition rate (IR) was 50% or more (high-sensitivity group) in 59.3% (16 cases) and it was under 50% (low-sensitivity group) in 40.7% (11 cases). The 3-year OS rate was 100% in the high-sensitivity group and 62.34% in the low-sensitivity group. The 3-year RFS rate was 83.33% in the high-sensitivity group and 24.24% in the low-sensitivity group. Thus, the 3-year OS rate and the 3-year RFS rate were higher in the high-sensitivity group than in the low-sensitivity group. No adverse events of grade 3 or greater severity were observed.ConclusionsThe results of the chemosensitivity test were correlated with the patient outcome. Therefore, such results might be useful for individualizing cancer chemotherapy and for determining future indications for postoperative adjuvant chemotherapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10120-010-0564-1", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1020959", 
        "issn": [
          "1436-3291", 
          "1436-3305"
        ], 
        "name": "Gastric Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "keywords": [
      "gastric cancer patients", 
      "postoperative adjuvant chemotherapy", 
      "relapse-free survival", 
      "chemosensitivity test", 
      "adjuvant chemotherapy", 
      "cancer patients", 
      "overall survival", 
      "adverse events", 
      "RFS rates", 
      "OS rates", 
      "low-sensitivity group", 
      "high sensitivity group", 
      "culture drug sensitivity test", 
      "collagen gel droplet", 
      "lymph node dissection", 
      "drug sensitivity test", 
      "inhibition rate", 
      "oral fluoropyrimidine", 
      "node dissection", 
      "growth inhibition rate", 
      "surgical treatment", 
      "clinical outcomes", 
      "predicts outcome", 
      "surgical specimens", 
      "patient outcomes", 
      "grade 3", 
      "patients", 
      "chemotherapy", 
      "greater severity", 
      "future indications", 
      "cancer chemotherapy", 
      "outcomes", 
      "ConclusionsThe results", 
      "gel droplet", 
      "survival", 
      "group", 
      "fluoropyrimidines", 
      "dissection", 
      "severity", 
      "rate", 
      "test", 
      "treatment", 
      "indications", 
      "events", 
      "years", 
      "D2", 
      "study", 
      "specimens", 
      "results", 
      "correlation", 
      "Such results", 
      "research", 
      "topic", 
      "topic of research", 
      "droplets"
    ], 
    "name": "Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively", 
    "pagination": "231-237", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043364490"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10120-010-0564-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21128058"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10120-010-0564-1", 
      "https://app.dimensions.ai/details/publication/pub.1043364490"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_516.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10120-010-0564-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10120-010-0564-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10120-010-0564-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10120-010-0564-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10120-010-0564-1'


 

This table displays all metadata directly associated to this object as RDF triples.

260 TRIPLES      21 PREDICATES      104 URIs      92 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10120-010-0564-1 schema:about N0de8db9d75ed4e88bf67b8e4abeec525
2 N0fcd67986fa643f7ad8b3009c83d8723
3 N13d380112f7444b1a8e6414666322382
4 N15ddbed1a12e4af48616d6c9a0e8b4cb
5 N344a7a39fc5a4e63a58aa9528c516695
6 N3a2d8bcbdb074b4aa64687059bed82c1
7 N44309d9be1ab4efd985f637c8cf2d9dc
8 N4c14db102d7a41ec82c6cdec87be2cf9
9 N4c7509b2e12f44ef9391d213e3c812f6
10 N521a3f51e0b84f9eb8700145984299cb
11 N91bb1972fa4349678dd9af16ca4b5def
12 N9e94943453264dfbb39dd31fc88b5cbc
13 Naa94a9930b58482da65460c81123e658
14 Nabcc2eacd13c40e9b18f34743a39b542
15 Nb6607b9ae8dd42c8af3adccf42d49217
16 Nc0eccbb83c074d06af51e1047a8afe03
17 Nd028ccb1076b447bbee6ba4502164341
18 Neae9cb3c349c43bfa969c5c65271aeec
19 Nfd102c7386454dd3a0852067a34fae9a
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author Ndb4b2a87c298417b9b239cbef1eab683
23 schema:citation sg:pub.10.1007/978-3-642-19022-3_5
24 sg:pub.10.1007/s00595-003-2569-4
25 sg:pub.10.1007/s10120-006-0366-7
26 sg:pub.10.1007/s10147-006-0618-x
27 schema:datePublished 2010-11
28 schema:datePublishedReg 2010-11-01
29 schema:description BackgroundChemosensitivity tests have long been discussed but remain a topic of research. In this study, we investigated the correlation between the results of a chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine and the clinical outcomes of gastric cancer patients treated with S-1, an oral fluoropyrimidine, as adjuvant chemotherapy.MethodsFor gastric cancer patients, we performed surgical treatment and a lymph node dissection of D2 or more. Afterwards, a chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine was performed, using the collagen gel droplet embedded culture drug-sensitivity test (CD-DST), in surgical specimens. All the patients received postoperative adjuvant chemotherapy with S-1 for 1 year, and the overall survival (OS), relapse-free survival (RFS), and adverse events were investigated.ResultsThe chemosensitivity test was performed for 27 patients. The growth inhibition rate (IR) was 50% or more (high-sensitivity group) in 59.3% (16 cases) and it was under 50% (low-sensitivity group) in 40.7% (11 cases). The 3-year OS rate was 100% in the high-sensitivity group and 62.34% in the low-sensitivity group. The 3-year RFS rate was 83.33% in the high-sensitivity group and 24.24% in the low-sensitivity group. Thus, the 3-year OS rate and the 3-year RFS rate were higher in the high-sensitivity group than in the low-sensitivity group. No adverse events of grade 3 or greater severity were observed.ConclusionsThe results of the chemosensitivity test were correlated with the patient outcome. Therefore, such results might be useful for individualizing cancer chemotherapy and for determining future indications for postoperative adjuvant chemotherapy.
30 schema:genre article
31 schema:isAccessibleForFree true
32 schema:isPartOf N7d455b12a3cd4ed08853ca0eb044ca3f
33 Nb0c2499995974dde98ae584aa19597e6
34 sg:journal.1020959
35 schema:keywords ConclusionsThe results
36 D2
37 OS rates
38 RFS rates
39 Such results
40 adjuvant chemotherapy
41 adverse events
42 cancer chemotherapy
43 cancer patients
44 chemosensitivity test
45 chemotherapy
46 clinical outcomes
47 collagen gel droplet
48 correlation
49 culture drug sensitivity test
50 dissection
51 droplets
52 drug sensitivity test
53 events
54 fluoropyrimidines
55 future indications
56 gastric cancer patients
57 gel droplet
58 grade 3
59 greater severity
60 group
61 growth inhibition rate
62 high sensitivity group
63 indications
64 inhibition rate
65 low-sensitivity group
66 lymph node dissection
67 node dissection
68 oral fluoropyrimidine
69 outcomes
70 overall survival
71 patient outcomes
72 patients
73 postoperative adjuvant chemotherapy
74 predicts outcome
75 rate
76 relapse-free survival
77 research
78 results
79 severity
80 specimens
81 study
82 surgical specimens
83 surgical treatment
84 survival
85 test
86 topic
87 topic of research
88 treatment
89 years
90 schema:name Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively
91 schema:pagination 231-237
92 schema:productId N14a6413571a0428381d6bd20bb9d598a
93 Nd626848888ae43e3bb30b819570283c4
94 Nd6ce3b8575534745b2553a3bfbcf9c25
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043364490
96 https://doi.org/10.1007/s10120-010-0564-1
97 schema:sdDatePublished 2022-12-01T06:28
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher N546d510ad6dd4eea820b38ca776d0403
100 schema:url https://doi.org/10.1007/s10120-010-0564-1
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N0de8db9d75ed4e88bf67b8e4abeec525 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Treatment Outcome
106 rdf:type schema:DefinedTerm
107 N0fcd67986fa643f7ad8b3009c83d8723 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Humans
109 rdf:type schema:DefinedTerm
110 N13d380112f7444b1a8e6414666322382 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Follow-Up Studies
112 rdf:type schema:DefinedTerm
113 N14a6413571a0428381d6bd20bb9d598a schema:name doi
114 schema:value 10.1007/s10120-010-0564-1
115 rdf:type schema:PropertyValue
116 N15ddbed1a12e4af48616d6c9a0e8b4cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Pyridines
118 rdf:type schema:DefinedTerm
119 N163b53a12e564003976b607260f94a7a rdf:first sg:person.01002352347.20
120 rdf:rest N639abda5a7d44a04a198ecd2dd61154e
121 N314d07778bdc4710baad590270cc5326 rdf:first sg:person.01365303072.99
122 rdf:rest N7789981fe92a4ab090f0fcd7a540df69
123 N344a7a39fc5a4e63a58aa9528c516695 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Tegafur
125 rdf:type schema:DefinedTerm
126 N3a2d8bcbdb074b4aa64687059bed82c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Antineoplastic Combined Chemotherapy Protocols
128 rdf:type schema:DefinedTerm
129 N44309d9be1ab4efd985f637c8cf2d9dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Neoplasm Staging
131 rdf:type schema:DefinedTerm
132 N4c14db102d7a41ec82c6cdec87be2cf9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Stomach Neoplasms
134 rdf:type schema:DefinedTerm
135 N4c7509b2e12f44ef9391d213e3c812f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Predictive Value of Tests
137 rdf:type schema:DefinedTerm
138 N521a3f51e0b84f9eb8700145984299cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Male
140 rdf:type schema:DefinedTerm
141 N546d510ad6dd4eea820b38ca776d0403 schema:name Springer Nature - SN SciGraph project
142 rdf:type schema:Organization
143 N639abda5a7d44a04a198ecd2dd61154e rdf:first sg:person.0623234375.11
144 rdf:rest N77b39f251e72425bbfb45890256cefa6
145 N7789981fe92a4ab090f0fcd7a540df69 rdf:first sg:person.01332141105.08
146 rdf:rest Nd0d5e0530a9c437ba5a0e339b4757fb3
147 N77b39f251e72425bbfb45890256cefa6 rdf:first sg:person.0663153457.61
148 rdf:rest rdf:nil
149 N7d455b12a3cd4ed08853ca0eb044ca3f schema:volumeNumber 13
150 rdf:type schema:PublicationVolume
151 N91bb1972fa4349678dd9af16ca4b5def schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Postoperative Care
153 rdf:type schema:DefinedTerm
154 N9e94943453264dfbb39dd31fc88b5cbc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Aged
156 rdf:type schema:DefinedTerm
157 Naa94a9930b58482da65460c81123e658 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Neoplasm Recurrence, Local
159 rdf:type schema:DefinedTerm
160 Nabcc2eacd13c40e9b18f34743a39b542 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Survival Analysis
162 rdf:type schema:DefinedTerm
163 Nb0c2499995974dde98ae584aa19597e6 schema:issueNumber 4
164 rdf:type schema:PublicationIssue
165 Nb6607b9ae8dd42c8af3adccf42d49217 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Chemotherapy, Adjuvant
167 rdf:type schema:DefinedTerm
168 Nbdc1e569057644f2a168da42f381cc6c rdf:first sg:person.01256300732.26
169 rdf:rest N314d07778bdc4710baad590270cc5326
170 Nc0eccbb83c074d06af51e1047a8afe03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Fluorouracil
172 rdf:type schema:DefinedTerm
173 Nd028ccb1076b447bbee6ba4502164341 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Oxonic Acid
175 rdf:type schema:DefinedTerm
176 Nd0d5e0530a9c437ba5a0e339b4757fb3 rdf:first sg:person.01202375123.92
177 rdf:rest N163b53a12e564003976b607260f94a7a
178 Nd626848888ae43e3bb30b819570283c4 schema:name pubmed_id
179 schema:value 21128058
180 rdf:type schema:PropertyValue
181 Nd6ce3b8575534745b2553a3bfbcf9c25 schema:name dimensions_id
182 schema:value pub.1043364490
183 rdf:type schema:PropertyValue
184 Ndb4b2a87c298417b9b239cbef1eab683 rdf:first sg:person.01274243317.10
185 rdf:rest Nbdc1e569057644f2a168da42f381cc6c
186 Neae9cb3c349c43bfa969c5c65271aeec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Female
188 rdf:type schema:DefinedTerm
189 Nfd102c7386454dd3a0852067a34fae9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Drug Combinations
191 rdf:type schema:DefinedTerm
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
196 schema:name Oncology and Carcinogenesis
197 rdf:type schema:DefinedTerm
198 sg:journal.1020959 schema:issn 1436-3291
199 1436-3305
200 schema:name Gastric Cancer
201 schema:publisher Springer Nature
202 rdf:type schema:Periodical
203 sg:person.01002352347.20 schema:affiliation grid-institutes:grid.459842.6
204 schema:familyName Watanabe
205 schema:givenName Masanori
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002352347.20
207 rdf:type schema:Person
208 sg:person.01202375123.92 schema:affiliation grid-institutes:grid.459842.6
209 schema:familyName Bou
210 schema:givenName Hideki
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202375123.92
212 rdf:type schema:Person
213 sg:person.01256300732.26 schema:affiliation grid-institutes:grid.459842.6
214 schema:familyName Tokunaga
215 schema:givenName Akira
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256300732.26
217 rdf:type schema:Person
218 sg:person.01274243317.10 schema:affiliation grid-institutes:grid.459842.6
219 schema:familyName Maejima
220 schema:givenName Kentaro
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274243317.10
222 rdf:type schema:Person
223 sg:person.01332141105.08 schema:affiliation grid-institutes:grid.410821.e
224 schema:familyName Kanno
225 schema:givenName Hitoshi
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332141105.08
227 rdf:type schema:Person
228 sg:person.01365303072.99 schema:affiliation grid-institutes:grid.410821.e
229 schema:familyName Kiyama
230 schema:givenName Teruo
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365303072.99
232 rdf:type schema:Person
233 sg:person.0623234375.11 schema:affiliation grid-institutes:grid.459842.6
234 schema:familyName Suzuki
235 schema:givenName Hideyuki
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623234375.11
237 rdf:type schema:Person
238 sg:person.0663153457.61 schema:affiliation grid-institutes:grid.410821.e
239 schema:familyName Uchida
240 schema:givenName Eiji
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663153457.61
242 rdf:type schema:Person
243 sg:pub.10.1007/978-3-642-19022-3_5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019330547
244 https://doi.org/10.1007/978-3-642-19022-3_5
245 rdf:type schema:CreativeWork
246 sg:pub.10.1007/s00595-003-2569-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003204853
247 https://doi.org/10.1007/s00595-003-2569-4
248 rdf:type schema:CreativeWork
249 sg:pub.10.1007/s10120-006-0366-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026373016
250 https://doi.org/10.1007/s10120-006-0366-7
251 rdf:type schema:CreativeWork
252 sg:pub.10.1007/s10147-006-0618-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010144924
253 https://doi.org/10.1007/s10147-006-0618-x
254 rdf:type schema:CreativeWork
255 grid-institutes:grid.410821.e schema:alternateName Department of Surgery, Nippon Medical School, Tokyo, Japan
256 schema:name Department of Surgery, Nippon Medical School, Tokyo, Japan
257 rdf:type schema:Organization
258 grid-institutes:grid.459842.6 schema:alternateName Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan
259 schema:name Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, 1-396 Kosugi-cho, Nakahara-ku, 211-8533, Kawasaki, Kanagawa, Japan
260 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...